Personnel Information


UETAKE Hiroyuki

Job title


Campus Career 【 display / non-display

  • 2014.12
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Specialized Surgeries, Professor
  • 2018.04
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Specialized Surgeries, Professor

Published Papers & Misc 【 display / non-display

  • Matsuyama T, Ishikawa T, Takahashi N, Yamada Y, Yasuno M, Kawano T, Uetake H, Goel A.. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer. Molecular Cancer. 2019.02; 18 (1): 19. ( PubMed, DOI )

  • Yasuno M, Uetake H, Ishiguro M, Mizunuma N, Komori T, Miyata G, Shiomi A, Kagimura T, Sugihara K. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival. Int. J. Clin. Oncol.. 2019.01; ( PubMed, DOI )

  • Ishiguro M, Ueno H, Kanemitsu Y, Hamaguchi T, Shida D, Simada Y. Current clinical practice of adjuvant chemotherapy for patients with 'high-risk' Stage II colorectal cancer in Japan: a questionnaire survey in the JCOG Study Group. Jpn. J. Clin. Oncol.. 2018.12; 48 (12): 1109-1112. ( PubMed, DOI )

  • Kusumoto T, Ishiguro M, Nakatani E, Yoshida M, Inoue T, Nakamoto Y, Shiomi A, Takagane A, Sunami E, Shinozaki H, Takii Y, Maeda A, Ojima H, Hashida H, Mukaiya M, Yokoyama T, Nakamura M, Munemoto Y, Sugihara K. Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer. ESMO Open. 2018.10; 3 (6): e000428. ( PubMed, DOI )

  • Raju Kandimalla, Feng Gao, Takatoshi Matsuyama, Toshiaki Ishikawa, Hiroyuki Uetake, Naoki Takahashi, Yasuhide Yamada, Carlos R Becerra, Scott Kopetz, Xin Wang, Ajay Goel. Genome-wide discovery and identification of a novel miRNA signature for recurrence prediction in stage II and III colorectal cancer. Clin. Cancer Res.. 2018.08; 24 (16): 3867-3877. ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • Shinichi Yamauchi, Yasuko Aoyagi, Yudai Yamamoto, Ayumi Takaoka, Hironobu Baba, Akifumi Kikuchi, Satoshi Okazaki, Takatoshi Matsuyama, Toshiaki Ishikawa, Yasuaki Nakajima, Kazuyuki Kojima, Hiroyuki Uetake, Yusuke Kinugasa, Kenichi Sugihara. Clinical significance of extended lateral lymph node dissection for patients with lower rectal cancer: A propensity score analysis in a multicenter retrospective study. SSO 2019 Annual Cancer Symposium (72nd Annual Cancer Symposium of the Society of Surgical Oncology) 2019.03.29 San Diego(USA)

  • Kumaki Y, Ikeda S, Rich TA, Shiotsu Y, Franovic A, Raymond VM, Kurzrock R, Lanman RB, Lee J, Mok TSK. Circulating cell-free DNA molecular profiling among East Asian patients reveals activating MET alterations are common in diverse advanced cancer types. ESMO Asia 2018 Congress 2018.11.24

  • Ishikawa T, Ishiguro M, Nakatani E, Ueno H, Uetake H, Murotani K, Matsui S, Tomita N, Shimada Y, Takahashi K, Kotake K, Watanabe M, Mochizuki H, Teramukai S, Sugihara K. Prognostic impact of MSI and 18qLOH in Stage II colon cancer:Aprospective biomarker study in the SACURA trial. ESMO 2018 2018.10.21 Munich (Germany)

  • Uetake H. 【Opening Remarks】. Gastrointestinal Cancer in CHICAGO 2018.06.26 Chicago (USA)

  • Takatoshi Matsuyama, Raju Kandimalla, Xuan Wang, Toshiaki Ishikawa, Naoki Uetake, Yasuhide Yamada, Masamichi Yasuno, Yusuke Kinugasa, Hiroyuki Uetake, Ajay Goel. A mesenchymal-associated transcriptomic signature has a prognostic and predictive potential in stage II and III colorectal cancer patients. American Association for Cancer Research (AACR 2018) 2018.04.16 Chicago (USA)

display all >>